By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics firm Iris International announced after the close of the market Tuesday that it has agreed to buy AlliedPath, an early-stage, high-complexity CLIA-certified laboratory, for up to $6 million.

Iris will pay $4.7 million in cash and an earn-out of up to $1.3 million subject to certain sales and earnings targets being reached during the next three years. The deal is expected to close by July 30.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.